EurekAlert! - Infectious and Emerging Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

No lab required: New technology can diagnose infections in minutes
(McMaster University) Engineering, biochemistry and medical researchers at McMaster University have combined their skills to create a hand-held rapid test for bacterial infections that can produce accurate, reliable results in less than an hour, eliminating the need to send samples to a lab. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Examining association of COVID-19 vaccination, facial nerve palsy
(JAMA Network)What The Study Did:Researchers found no association between recent vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine and risk of facial nerve palsy. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Association of COVID-19 pandemic with estimated life expectancy by race/ethnicity
(JAMA Network)What The Study Did: Researchers estimated the change in life expectancy associated with the COVID-19 pandemic in the United States by race/ethnicity. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Outcomes for COVID-19 patients 1 year after loss of smell
(JAMA Network)What The Study Did: Patients with COVID-19-related loss of smell were evaluated for one year after the diagnosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Incidence of bell palsy in patients with COVID-19
(JAMA Network)What The Study Did:The incidence of Bell palsy among patients with COVID-19 was compared with individuals vaccinated against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Study suggests scientists may need to rethink which genes control aging
(NIH/National Institute of Neurological Disorders and Stroke) National Institutes of Health researchers fed fruit flies antibiotics and monitored the lifetime activity of hundreds of genes that scientists have traditionally thought control aging. To their surprise, the antibiotics not only extended the lives of the flies but also dramatically changed the activity of many of these genes. Their results suggested that only about 30% of the genes traditionally associated with aging set an animal's internal clock while the rest reflect the body's response to bacteria. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Streptococcus pneumoniae sticks to dying lung cells, worsening secondary infection following flu
(University of Alabama at Birmingham) Researchers have found a further reason for the severity of dual infection by influenza and Streptococcus pneumonia -- a new virulence mechanism for a surface protein on the pneumonia-causing bacteria S. pneumoniae. This insight comes 30 years after discovery of that surface protein, called pneumococcal surface protein A. This mechanism had been missed in the past because it facilitates bacterial adherence only to dying lung epithelial cells, not to living cells. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Demystifying COVID-19
(Bentham Science Publishers) This book provides the reader a comprehensive understanding of the disease, its diagnosis and treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Clinical and pre-clinical antimicrobial drug development
(Bentham Science Publishers) The ninth volume of 'Frontiers in Anti-Infective Drug Discovery' discusses clinical and pre-clinical antimicrobial drug development, it also focuses on drugs to treat leishmaniosis and dengue fever. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Decoding humans' survival from coronaviruses
(University of Adelaide) An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Repurposing rheumatology drugs for COVID-19
(European Alliance of Associations for Rheumatology) COVID-19 can be mild, or even without symptoms at all. But it can also cause severe disease, leading to respiratory problems, organ failure, and death. Research on the immune mechanisms involved in people with severe COVID-19 has shown that they have widespread inflammation. Early on in the pandemic, several immunomodulatory anti-inflammatory treatments commonly used in people with rheumatic and musculoskeletal diseases (RMDs) were proposed as possible options for people with severe COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Spreading of infections = need for collaboration between biology and physics
(University of Copenhagen - Faculty of Science) Researchers at the Niels Bohr Institute, University of Copenhagen, together with epidemiologist Lone Simonsen from Roskilde University form part of the panel advising the Danish government on how to tackle the different infection-spreading situations we have all seen unfold over the past year. Researchers have modelled the spread of infections under a variety of scenarios, and the Coronavirus has proven to not follow the older models of disease spreading. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Versatile, fast and reliable SARS-CoV-2 antibody assay
(Technical University of Munich (TUM)) During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies - either through infection or vaccination. Researchers at the Technical University of Munich (TUM) have now developed such a rapid antibody test. It provides the result in only eight minutes; the aim is to further reduce the process time to four minutes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Case report: Remdesivir induced dangerously low heart rate in COVID-19 patient
(Elsevier) After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment. The case is discussed in Heart Rhythm Case Reports, an official journal of the Heart Rhythm Society, published by Elsevier. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2021 Category: Infectious Diseases Source Type: news

Cutaneous reactions after mRNA COVID-19 vaccines
(JAMA Network) What The Study Did: Hospital employees were surveyed about symptoms such as a rash, itching, hives or swelling around the face after receiving a messenger RNA COVID-19 vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2021 Category: Infectious Diseases Source Type: news